BERLIN (Reuters) -German medical technology company Brainlab on Tuesday became the latest IPO candidate in the region to put ...

Medical technology company Brainlab postponed its initial public offering in Frankfurt on Tuesday, the latest deal to be shelved as Europe’s market for new listings remains cautious. Munich-based ...

German medical technology company’s decision comes after car parts retailer Autodoc pushes back flotation plans ...

The CEO of German medical technology firm Brainlab said on Tuesday that geopolitical uncertainties had prompted the decision ...

Cirsa’s IPO comprises a €400m primary offering and a €53m secondary offering by LHMC Midco, a holding of Blackstone. Morgan ...

Germany's Brainlab postponed its planned initial public offering indefinitely, dealing another blow to Europe's IPO market.

BERLIN (Reuters) -German medical technology firm Brainlab is expected to price at 80 euros ($93.86) per share in its initial public offering planned for Thursday, according to a statement from a ...

German medical technology firm Brainlab said on Monday it had set the price range for its initial public offering (IPO) at 80 ...

Brainlab, the German medical technology company, set the price range for its forthcoming IPO at €80 to €100 a share on Monday ...

After the slowest first half for European initial public offerings in more than a decade, dealmakers are banking on several large transactions to reignite the market later this year.

Medical technology software firm Brainlab AG and its shareholders are seeking up to €400 million ($460 million) in its Frankfurt initial public offering, as several European companies look to list ...

Brainlab had already planned an IPO in 2001, but it was canceled two days before the planned date on July 5. At that time, 5.1 million shares were to be placed at a bookbuilding range of 13.50 to 17 ...